Skip to main content
Premium Trial:

Request an Annual Quote

Motorola Completes Development of Low-density Clinical Microarrays

NEW YORK, Oct. 30 – Motorola announced Monday it has completed development of its eSensor low-density clinical microarray, and will begin manufacturing this instrument in the second quarter of next year.

The company’s Clinical Micro Sensors business unit is making the sensors to do DNA testing for health care, agriculture, and environmental monitoring, as previously reported in GenomeWeb.

Motorola’s own studies have found the chips to be effective in detecting SNPs, panels of bacterial or viral targets, and genetically modified crops, the company said.

The sensors, which have small numbers of probes, run on the principle of bioelectronics, which uses organic molecules to form electronic circuits that detect numerous DNA and RNA targets at once.

Motorola expects to manufacture and ship the first eSensor instruments to researchers in agricultural diagnostics.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.